U.S. Retail Clinics Market Size, Share & Trends Analysis Report By Ownership (Retail Owned, Hospital Owned), By Diagnosis (Immunization, General Symptoms, General Screening & Examination, Injuries), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED: September 20, 2024

PAGES: 80 Pages

DELIVERY TIME: 2-10 business days

ADD TO COMPARE

SELECT AN OPTION

Description

U.S. Retail Clinics Market Growth & Trends:

The U.S. retail clinics market size is anticipated to reach USD 6.86 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 9.7% from 2024 to 2030. Convenient access and affordable prices are expected to boost growth of the U.S. retail clinics market.

These settings act as an alternate channel for provision of primary care and offer basic healthcare services at affordable prices, lowering the need to visit the Emergency Department. Around 10% of the visits to the emergency departments in the U.S. could be treated outside of the ED. This reduces the out-of-pocket costs paid for the visit to an ED.

These settings usually operate during all seven days of a week. In addition, they have shorter waiting duration and appointments are not mandatory. Convenience and flexibility of visit hours help people easily access clinics that are located in grocery stores, shopping malls, and other locations.

In addition, adoption of information technology, highlighted by the use of EHRs helps these settings maintain a streamlined patient record that can be shared across different healthcare systems. This patient data could also be used to implement population health management strategies, for better patient outcomes, which could ease the U.S. healthcare's transformation into a value-based care model from a fee-for-service (FFS) model.

U.S. Retail Clinics Market Report Highlights:

Retail owned segment dominated the market with a share of 81.8% in 2023. Companies such as CVS Health, own, operate, or provide management for its MinuteClinic clinics.
Immunization segment held the largest revenue share of 25.3% of the market in 2023. During and after the COVID-19 pandemic, the retail clinics market observed increasing popularity among people for vaccinations as these clinics provided the testing facilities as well.
The Southeast region witnessed the largest revenue share of 34.2% in 2023 owing to the increasing utilization of accessible & non-emergency healthcare services in the region.

Product Code: GVR-1-68038-615-8

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. U.S. Retail Clinics Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. U.S. Retail Clinics Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. U.S. Retail Clinics Market: Ownership Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. U.S. Retail Clinics Market: Ownership Movement Analysis, 2023 & 2030 (USD Million)
4.3. Retail Owned
- 4.3.1. Retail Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Hospital Owned
- 4.4.1. Hospital Owned Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 5. U.S. Retail Clinics Market: Diagnosis Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. U.S. Retail Clinics Market: Diagnosis Movement Analysis, 2023 & 2030 (USD Million)
5.3. Immunization
- 5.3.1. Immunization Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. General Symptoms
- 5.4.1. General Symptoms Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5. Injuries
- 5.5.1. Injuries Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.6. General Screening & Examination
- 5.6.1. General Screening & Examination Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.7. Acute Respiratory Disease & Infection
- 5.7.1. Acute Respiratory Disease & Infection Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.8. Urinary Tract Infections
- 5.8.1. Urinary Tract Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.9. Ear Infections
- 5.9.1. Ear Infections Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.10. Sprains, Strains, and Fractures
- 5.10.1. Sprains, Strains, and Fractures Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.11. Others
- 5.11.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 6. U.S. Retail Clinics Market: Regional Estimates & Trend Analysis

6.1. U.S. Retail Clinics Market Share, By Region, 2023 & 2030, USD Million
6.2. Southeast
- 6.2.1. Southeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.3. Midwest
- 6.3.1. Midwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Southwest
- 6.4.1. Southwest U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Northeast
- 6.5.1. Northeast U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)
6.6. West
- 6.6.1. West U.S. Retail Clinics Market Estimates and Forecasts, 2017 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. CVS Health
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
- 7.4.2. Kroger Health
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
- 7.4.3. Walgreens
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
- 7.4.4. Advocate Health Care
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
- 7.4.5. Kaiser Foundation Health Plan, Inc.
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
- 7.4.6. Walmart
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
- 7.4.7. Bellin Health Systems
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
- 7.4.8. Geisinger Health
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
- 7.4.9. Target
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives